[Genetic and clinical aspects of lissencephaly]

A Verloes1, M Elmaleh, M Gonzales

  • 1INSERM U676, Paris. alain-verloes@rdb-aphp.fr

Revue Neurologique
|June 16, 2007
PubMed

Insights

Lissencephaly is a rare brain malformation characterized by smooth brain surfaces and abnormal cortical development, leading to severe developmental delays and health issues. Classification includes classical (Type I) and cobblestone (Type II) forms, with genetic causes identified for some subtypes.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Genetics

Background:

  • Lissencephaly encompasses rare brain malformations defined by simplified or absent cortical folding and disorganized cortical layers due to neuronal migration defects.
  • Affected children exhibit feeding/swallowing difficulties, muscle tone anomalies, seizures (infantile spasms), and severe psychomotor retardation.

Purpose of the Study:

  • To review the classification and underlying etiologies of lissencephaly.
  • To highlight the clinical manifestations and management strategies for lissencephaly.

Main Methods:

  • Classification of lissencephaly into classical (Type I) and cobblestone (Type II) forms based on cortical appearance and associated malformations.
  • Identification of genetic etiologies for specific lissencephaly subtypes, including mutations in LIS1, TUBA3, DCX, and ARX genes.

Main Results:

  • Classical lissencephaly (Type I) shows a thickened cortex with disorganized layers, while cobblestone lissencephaly (Type II) presents with global cerebral disorganization and an uneven cortical surface.
  • Genetic causes identified include LIS1 gene anomalies (isolated lissencephaly, Miller-Dieker syndrome), TUBA3 and DCX gene anomalies, and ARX gene mutations (XLAG syndrome).
  • Incidence of Type I lissencephaly is approximately 1 in 100,000 births. Management is symptomatic, addressing feeding, motor, and seizure issues, with often severe outcomes.

Conclusions:

  • Lissencephaly is a complex group of disorders with diverse classifications and genetic underpinnings.
  • Current management focuses on symptomatic relief, as the associated encephalopathy is often severe, leading to significant disability.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.